Supplying Functional Ingredients to the US & EU: What Chinese Exporters Must Get Right

Supplying to the US & EU: What Chinese Exporters Must Get Right

Meta Title: Supplying Ingredients to the US & EU Market: A Compliance Guide for ExportersMeta Description: What Chinese functional ingredient suppliers and their customers need to know about US (DSHEA, GRAS) and EU (Novel Food) compliance, documentation, and due diligence.Keywords: ingredient export compliance, US dietary supplement rules, EU novel food, GRAS, functional ingredients China

Answer at a glance: Selling functional ingredients into the US and EU requires understanding two different frameworks: the US regulates dietary ingredients under DSHEA with a GRAS or New Dietary Ingredient (NDI) pathway, while the EU requires Novel Food authorization for ingredients not consumed in significant amounts before 1997. Exporters should prepare a documentation package — COAs, GMP evidence, ingredient specifications, and regulatory dossiers — and let buyers verify compliance with their own regulatory counsel.

Why Compliance Is a Two-Sided Responsibility

In international ingredient trade, compliance is shared. The exporter supplies accurate, complete documentation about what the ingredient is and how it is produced. The importer/brand verifies that the ingredient, dose, and claims comply with the rules of the market where the finished product is sold. The most successful suppliers make the buyer's regulatory job as easy as possible — and buyers choose suppliers who can.

The US Framework

Dietary Supplements: DSHEA

Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, dietary ingredients used in supplements fall into two categories:

• Grandfathered ingredients — those sold in the US before October 15, 1994, can be used without pre-market approval.

• New Dietary Ingredients (NDI) — ingredients not marketed before that date require an NDI notification to the FDA unless they are GRAS for their intended use.

What this means for exporters: A supplier cannot simply tell a US buyer "it's fine." The buyer will need to know whether your ingredient is grandfathered, has an NDI filing, or is covered by GRAS determination. Be ready to discuss this at the inquiry stage.

GRAS (Generally Recognized As Safe)

GRAS is a US-specific concept — an ingredient can be considered GRAS when qualified experts agree it is safe under the conditions of its intended use, based on published evidence or a self-affirmed GRAS determination. GRAS status is not granted by the FDA in the form of a simple certificate; it is a determination supported by a dossier.

Good Manufacturing Practice

The US requires dietary supplement production to follow FDA 21 CFR Part 111 GMP rules. Even if the supplier is overseas, the finished product sold in the US must have been manufactured in a GMP-compliant facility, with testing and documentation to match.

The EU Framework

Novel Food Regulation

In the EU, any food or ingredient not consumed to a significant degree in the EU before May 15, 1997, is a "novel food" and requires pre-market authorization from the European Commission, following an EFSA safety evaluation. This is a long and expensive process — authorization can take several years.

Key implications:

• Botanicals and ingredients new to the EU market need authorization before use.

• Traditional-use status must be verifiable — documentation matters.

• EU regulations are harmonized but enforcement is national, so market entry should be validated market by market.

Food Supplements Directive

The EU also has a positive list of vitamins and minerals permitted in food supplements, plus rules for other ingredients. National differences exist (for example, in France, some plant substances face additional restrictions), so exporters should confirm the specific country's rules.

The Documentation Package Exporters Should Prepare

A strong documentation package answers most buyer due-diligence questions before they are asked:

1. Product specification sheet — with marker content, test methods, and physical properties

1. Batch-specific COA — full analytical panel (assay, heavy metals, microbials, moisture)

1. GMP/certification evidence — ISO, GMP, Halal, Kosher, organic certificates with validity and scope

1. Process description — extraction, concentration, drying, and any carriers/excipients used

1. Allergen declaration — including processing aids

1. Stability data — if available, for the intended conditions

1. Regulatory status statement — what the supplier can and cannot claim about the ingredient's legal status in each market

Best Practices for Cross-Border Ingredient Trade

• Never overclaim regulatory status. If you don't know, say so and offer to obtain third-party verification.

• Keep batch documentation consistent — the COA, label, and export documents must all reference the same batch.

• Prepare for audits — serious buyers may request a factory audit or video walkthrough.

• Work with regulatory consultants — for complex categories (botanicals, novel foods), a qualified consultant is worth the cost.

FAQ

Q: If my product is sold as a supplement in the US, does the exporter need an FDA registration?A: The facility producing dietary supplements sold in the US must register with the FDA and follow GMP rules. Confirm your facility's registration status with your buyer.

Q: Is GRAS the same as an FDA approval?A: No — GRAS is a determination of safety based on expert consensus; it is not an "approval." The FDA does maintain a notification pathway, but self-affirmed GRAS is common.

Q: How long does EU Novel Food authorization take?A: The process can take several years, including the EFSA scientific evaluation. Plan well ahead of market entry if your ingredient needs authorization.

Hunan Dye Natural Resource Inc. provides documentation-supportive supply of functional ingredients — specifications, COAs, and regulatory dossiers — to help your brand complete due diligence efficiently. Contact us for a documentation sample.